Skip to Main Content

Paper Details

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.
JCI Insight
28
2021
CR3022, Fc, Fc variants, SARS-CoV, SARS-CoV-2, WT IgG1, hamster, infected cells, mice, monoclonal antibody CR3022, mouse, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Stephanie FischingerRagon Institute of MGH
Stephanie FischingerUniversity of Duisburg-Essen
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Sarah R LeistUniversity of North Carolina at Chapel Hill
Natalia A KuzminaUniversity of Texas Medical Branch
Natalia A KuzminaGalveston National Laboratory, Institute for Human Infections and Immunity, University of Texas Medical Branch
Nadia StormBoston University School of Medicine
Nadia StormBoston University
Todd J Suscovich
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S Baric
Ralph S BaricLineberger Comprehensive Cancer Center, University of North Carolina
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S Baric
Ralph S BaricLineberger Comprehensive Cancer Center, University of North Carolina
Galit AlterRagon Institute of MGH
  • 1 - 16

Datasets

Release 1.2